Exacerbated ischemic brain damage in type 2 diabetes via methylglyoxal-mediated miR-148a-3p decline
Blood-brain barrier damage caused by methylglyoxal-mediated miR-148a-3p downregulation may provide a novel target for the therapeutic intervention for the treatment of stroke patients with diabetes.
Authors
- Di Hu (ORCID: https://orcid.org/0000-0002-1627-014X)
- Cheng Huang (ORCID: https://orcid.org/0000-0002-5517-0854)
- Zhenguo Yang (ORCID: https://orcid.org/0000-0001-7674-977X)
- Wenhui Huang (ORCID: https://orcid.org/0000-0003-0636-8562)
- Xueyi Wen
- Chi Kwan Tsang (ORCID: https://orcid.org/0000-0002-0133-1544)
- Hesong Xie
- Keshen Li (ORCID: https://orcid.org/0000-0003-2389-7706)
- Chao Guo Yan
- Kejing He
Institutions
- First Affiliated Hospital of Jinan University (CN)
Publication Details
- Journal
- BMC Medicine
- Published
- 2024-11-26
- DOI
- https://doi.org/10.1186/s12916-024-03768-3
- Citations
- 7
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 2.00
Funders
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province